GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ace (ACE) [hlAlert]

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions
and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.
( Total: 21 Current Stock Recommendations )
Ace   (21)
Hold 19% Buy 81%
Related companies
Progressive ...   (26)
Sell 15% Hold 50% Buy 35%
Chubb Corporation ...   (22)
Sell Hold 41% Buy 55%
Hartford Financial ...   (18)
Hold 33% Buy 67%
The Travelers ...   (26)
Sell Hold 46% Buy 42%
American ...   (24)
Sell Hold 62% Buy 29%
Allstate ...   (26)
Sell Hold 46% Buy 50%
Cincinnati ...   (9)
Sell 22% Hold 33% Buy 44%
Markel Corporation   (10)
Sell Hold 40% Buy 50%
Xl Capital   (23)
Sell Hold 52% Buy 43%
Servicenow Inc.   (20)
Hold Buy 90%
Filter by Gains:   
  
Rating:
Buy ACE
up 14.72 %
Ace (ACE) rated Buy with price target $140 by MKM Partners
Tuesday,  Jan 5, 2016  11:25 AM ET

Rating:
Buy ACE
down 7.70 %
Ace (ACE) rated Overweight by Morgan Stanley
Thursday,  Nov 12, 2015  10:25 AM ET

Rating:
Buy ACE
up 71.19 %
Ace (ACE) rated Buy with price target $125 by UBS
Friday,  Dec 19, 2014  11:25 AM ET

Rating:
Hold ACE
up 78.96 %
Ace (ACE) downgraded to Neutral by Citigroup
Wednesday,  Feb 12, 2014  8:25 AM ET

Rating:
Buy ACE
up 88.71 %

Rating:
Buy ACE
up 16.43 %
Ace (ACE) rated Overweight with price target $117 by Barclays
Friday,  Nov 22, 2013  12:25 PM ET

Rating:
Hold ACE
Ace (ACE) rated Hold by Sandler O'Neill
Thursday,  Oct 24, 2013  10:25 AM ET

Rating:
Buy ACE
up 14.72 %
Ace (ACE) rated Buy with price target $115 by MKM Partners
Wednesday,  Oct 23, 2013  11:25 AM ET

Rating:
Buy ACE
up 11.86 %
Ace (ACE) rated Buy with price target $129 by Guggenheim
Wednesday,  Sep 18, 2013  8:25 AM ET

Rating:
Buy ACE
up 16.43 %
Ace (ACE) rated Overweight with price target $112 by Barclays
Wednesday,  Jul 24, 2013  12:25 PM ET

Rating:
Buy ACE
up 17.31 %
Ace (ACE) rated Buy by Nomura
Wednesday,  Jun 5, 2013  9:25 AM ET

Rating:
Hold ACE
Ace (ACE) rated Hold with price target $94 by Deutsche Bank
Wednesday,  Apr 24, 2013  4:25 PM ET

Rating:
Buy ACE
up 14.72 %
Ace (ACE) rated Buy with price target $105 by MKM Partners
Tuesday,  Apr 23, 2013  11:25 AM ET

Rating:
Buy ACE
up 16.43 %
Ace (ACE) rated Overweight with price target $103 by Barclays
Tuesday,  Apr 2, 2013  12:25 PM ET

Rating:
Hold ACE
up 6.27 %

Your Recent Stocks
SymbolLastChange
ACE 115.06 up  11.01 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy